Recent Advances and Future Perspectives in Sepsis Translational Research
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 4896
Special Issue Editors
Interests: sepsis; shock; translational research; animal model; therapeutics
Interests: sepsis; shock; translational research; animal model; therapeutics
Interests: post-intensive care syndrome; ICU-acquired weakness; aging; immunosenescence; sepsis; end-of life
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Sepsis is a severe medical condition affecting all age groups, with approximately 50 million annual cases resulting in 11 million deaths worldwide. As sepsis is an enduring global health priority, researchers have worked over the decades to understand its underlying pathophysiology in hopes of developing safe and effective therapeutics. Additionally, establishing optimal animal sepsis models and designing well-designed clinical trials are essential for translating therapeutics from the research laboratory to patient care.
This Special Issue welcomes all manuscripts providing insight into basic, translational, and applied clinical investigation in sepsis research. Manuscripts discussing new animal models to test potential therapeutics and reports exploring the molecular mechanisms of sepsis are of particular interest. We are also interested in sepsis-related conditions and complications, such as sepsis-associated encephalopathy, immunosenescence, muscle atrophy, and secondary infection. In this Special Issue, we will detail both the cutting edge of current sepsis research and related conditions and provide a road map for the next generation of doctors and scientists on the challenges that still lie ahead for the field.
Dr. Manabu Kinoshita
Dr. Kazumichi Fujioka
Prof. Dr. Shigeaki Inoue
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- sepsis
- shock
- septic shock
- translational research
- animal model
- immune response
- inflammation
- infection
- oxidative stress
- therapeutics